Unjoni Ewropea - Malti - EMA (European Medicines Agency)

deciphera pharmaceuticals (netherlands) b.v. - ripretinib - tumur stromali gastrointestinali - aġenti antineoplastiċi - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumour (gist) who have received prior treatment with three or more kinase inhibitors, including imatinib.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

recordati rare diseases - żingu - deġenerazzjoni epatoġenika - oħra tal-passaġġ alimentari u tal-metaboliżmu-prodotti, - trattament tal-marda ta 'wilson.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

biomarin international limited - sapropterin dihydrochloride - phenylketonurias - oħra tal-passaġġ alimentari u tal-metaboliżmu-prodotti, - kuvan huwa indikat għall-kura ta 'hyperphenylalaninemia (hpa) f'adulti u pazjenti pedjatriċi ta' kull età b'fenilketonurja (pku) li ntwera li jirrispondu għal trattament bħal dan. kuvan huwa indikat ukoll għal-kura ta 'hyperphenylalaninaemia (hpa) f'persuni adulti u pazjenti tfal ta' kull età b'defiċjenza ta ' tetrahydrobiopterin (bh4) u li jkunu wrew rispons għal din il-kura.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

gmp-orphan sa - trientene tetraidroklorur - deġenerazzjoni epatoġenika - oħra tal-passaġġ alimentari u tal-metaboliżmu-prodotti, - cuprior huwa indikat għall-kura ta 'wilson tal-marda fl-adulti, l-adoloxxenti u t-tfal ta' ≥ 5 snin li ma jittollerawx d-penicillamine-terapija.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

zoetis belgium sa - sevoflurane - anestetiċi ġenerali, - dogs; cats - għall-induzzjoni u l-manutenzjoni ta 'l-anestesija fil-klieb u l-qtates.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

chanelle pharmaceuticals manufacturing limited - sevoflurane - anestetiċi ġenerali, - dogs; cats - għall-induzzjoni u l-manutenzjoni ta 'l-anestesija.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

amicus therapeutics europe limited - miglustat - mard tal-Ħażna tal-glukoġen tat-tip ii - prodotti oħra alimentari u metaboliżmu - opfolda (miglustat) is an enzyme stabiliser of cipaglucosidase alfa long-term enzyme replacement therapy in adults with late-onset pompe disease (acid α- glucosidase [gaa] deficiency).

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

ipsen pharma - cabozantinib (s)-malate - carcinoma, renal cell; carcinomas, hepatocellular - aġenti antineoplastiċi - renal cell carcinoma (rcc)cabometyx is indicated as monotherapy for the treatment of advanced renal cell carcinoma (rcc):in treatment-naïve adults with intermediate or poor risk,in adults following prior vascular endothelial growth factor (vegf)-targeted therapy. cabometyx, in combination with nivolumab, is indicated for the first-line treatment of advanced renal cell carcinoma in adults. hepatocellular carcinoma (hcc)cabometyx is indicated as monotherapy for the treatment of hepatocellular carcinoma (hcc) in adults who have previously been treated with sorafenib.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

eisai gmbh - lenvatinib mesilate - karċinoma, Ċellula renali - aġenti antineoplastiċi - kisplyx is indicated for the treatment of adults with advanced renal cell carcinoma (rcc):in combination with pembrolizumab, as first-line treatment (see section 5. in combination with everolimus, following one prior vascular endothelial growth factor (vegf)-targeted therapy.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

amneal pharma europe ltd - levodopa, carbidopa - marda ta 'parkinson - mediċini kontra l-parkinson - trattament sintomatiku ta 'pazjenti adulti bil-marda ta' parkinson.